BioMarin Pharmaceutical | 债务利息支出



Interest Expense On Debt 更改 日
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Gilead Sciences USD 248M 10M 2024-12
Incyte USD 419K 355K 2024-12
Insmed USD 19.8M 532K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Moderna USD 6M 0 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
PTC Therapeutics USD 42.11M 1.09M 2024-09
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



BioMarin Pharmaceutical 债务利息支出 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2025.